Genmab - ADR (GMAB) Company Profile & Statistics

Genmab - ADR
GMAB
(Nasdaq - US)
Closed
20.47
+0.02 (+0.10%)
in:usd•As of: Nov 21, 2024 15:59 UTC -5
Open
20.51
High
20.62
Low
20.36

About Genmab - ADR

CEO

Jan G. van de Winkel

Headquarters

carl jacobsens vej

valby, g7 2500, denmark

Auditor

PricewaterhouseCoopers

Employees

2,204

Share Holders

N/A

Website

www.genmab.com

Industry

pharmaceuticals major

Sector

health technology

Company Overview

Genmab A/S is a biotechnology company. It specializes in development of antibody therapeutics for the treatment of cancer. The company's product pipeline includes DARZALEX(R), Arzerra(R), tisotumab vedotin, enapotamab vedotin, HexaBody-DR5/DR5(R) and DuoBody-CD3xCD20 (R),which are in clinical stage. Genmab A/S is based in Copenhagen V, Denmark.

Genmab - ADR Statistics

Valuation Measures

Market Capitalization ²	13.55B
Enterprise Value	12.61B
Enterprise Value/EBITDA (ttm)	13.70
Price to Earnings Ratio (ttm)	19.90
Price to Book (mrq)	2.88
Price to Sales (ttm)	4.72
Price to Cash (ytd)	16.53

Profitability

Gross Margin (ttm)	96.10%
Operating Margin (ttm)	23.55%
Profit Margin (ttm)	23.57%
Return on Equity (ttm)	14.64%
Return on Invested Capital (ttm)	14.56%
Return on Assets (ttm)	12.37%

Income Statement

Revenue (ttm)	2.87B
Revenue Per Share (ttm)	N/A
Gross Profit (ttm)	2.76B
EBITDA (ttm)³	920.44M
Net Income Avi to Common (ttm)	672.95M
Diluted EPS (ttm)	1.03

Share Statistics

Beta (5Y Monthly)	0.99
52-Week Change	-36.94%
S&P500 52-Week Change	30.55%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	N/A
Dividend Yield	0.00%
Float ⁴	651.58M
% Held by Insiders	1.54%
% Held by Institutions	7.07%

Balance Sheet

Total Cash (mrq)	2.55B
Total Cash Per Share (mrq)	N/A
Total Debt (mrq)	0.00
Total Debt/Equity (mrq)	0.00%
Current Ratio (mrq)	5.17%
Quick Ratio (mrq)	5.15%
Book Value Per Share (mrq)	7.11

Cash Flow

Operating Cash Flow Per Share (ytd)	1.13
Free Cash Flow (ytd)	731.99M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Genmab - ADR

Trade With A Regulated Broker